Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Potawatomi Support Services now offers a rapid and comprehensive turnkey surveillance and screening solution for COVID-19 testing


Marichu Relativo, General Manager – Potawatomi Support Services

Potawatomi Support Services (PSS) has teamed up with Beechtree Diagnostic, a CLIA-certified (Clinical Laboratory Improvement Amendments) high complexity lab, and can now perform rapid antibody screen testing and PCR confirmatory testing. Screen and confirmatory testing will include full CLIA oversight, training, and reporting. Potawatomi Support Services can now provide rapid testing kits to agencies to conduct their own testing for surveillance and risk management purposes as defined by the FDA. Potawatomi Support Services (PSS) has the rapid testing kit available for immediate shipment. In addition, Potawatomi Support Services offers a training video to assist in training your personnel to conduct the sampling and verify the results on-site within minutes.

Potawatomi Support Services’ main goal is getting agencies and companies back to work by offering a comprehensive turnkey surveillance and screening (as defined by the FDA) solution for COVID-19 testing. Potawatomi Support Services’ approach uses the FDA Emergency Use Authorized Healgen COVID-19 “Coronavirus” lgG/lgM Rapid Test Kit. The program is designed to administer rapid antibody testing kits in the field. This solution provides FDA- and CLIA-compliant, scientifically reliable surveillance or screen testing at a cost and speed that allows the organization to more accurately make decisions to manage the current health crisis.

Our Potawatomi Support Solutions FDA Emergency Use Authorized COVID-19 lgG/lgM Rapid test kits provide a cost-effective, timely, accurate, and reliable solution. Testing capabilities have evolved quickly through this crisis. There are two primary testing types: Antibody and PCR Testing. Unfortunately, there have been significant challenges with PCR testing, principally due to supply chain issues for test kits and reagents, causing significant delays and increased cost. Our rapid test kit allows organizations to conduct efficient surveillance testing or screen high numbers of patients quickly through a CLIA-certified lab, only confirming through PCR testing when patients are symptomatic or receive a positive screen result.

Agencies interested in purchasing these rapid test kits for surveillance and/or screening purposes for immediate delivery, contact Potawatomi Support Services.

About the teaming partners:

Potawatomi Support Solutions is an SBA-Certified 8(a) subsidiary of Potawatomi Business Development Corporation (PBDC). As an American Indian Tribal (AIT) Corporation, PBDC-Federal Group provides Potawatomi Support Services with the corporate infra-structure, processes, and financial support of a much larger organization, allowing our customers to recognize the benefits while still maintaining access to small and agile Primes. As part of the PBDC family of companies, PSS shares common administrative services with each other. This support grants us access to human capital, well-proven processes, and a wealth of knowledge that spans over all twelve companies.

Beechtree Diagnostics was established in 2015 to fill the gap left by other toxicology laboratories in providing quality testing, reporting and service to physicians and professionals dealing with the difficulties of Mental Health, Substance Use Disorder, Pain Management Treatment, as well as Court Ordered Substance Abuse Testing. Beechtree has created unique processes to directly benefit medical professionals and their patients. Beechtree is a CLIA certified and CAP accredited high complexity laboratory located in Utah and Alaska. Beechtree stands ready to support organizations with COVID testing requirements, using the CLIA high complexity certification to operate testing under the FDA Emergency Use Authorizations (EUA).

Share article on social media or email:

Psychic Predicts Trump as President for a 2nd Term


News Image

The next four years feels very similar to Lyndon Johnson’s presidency, with a smidgen of Abraham Lincoln’s presidency thrown into it.

Kelle Sutliff has 18 years of experience behind her in readings, psychic investigations on missing person and cold cases, and has always seen President Trump serve two terms. She made her first prediction as documented in The Boston Herald,18 months prior saying, it would be Hillary Clinton and Donald Trump as the last two candidates in the 2016 election.

“I knew at 9:28 PM that election night that the shift would happen in his favor and he would win.” said Sutliff.

For 2020, I see him being elected again, but with some challenges. Mercury is retrograde and is direct with Saturn, which can bring some chaos. Sutliff believes it’s the worst time to have a presidential election right now. She says, “Be prepared to have ballots lost, conspiracy and voting not counted correctly. Needless to say, people of course getting mad and taking their ball home and not playing anymore!” It’s poor timing and the announcement of Trump being president will be delayed.

She adds, the next four years you will see a lot of medical reform, balance in racial injustice and more financial allocations towards healing our environment – due to the world entering into the age of Aquarius starting in the Fall of 2020. However, with this new age comes those 1960’s-like movements coming back at us. Sutliff says, “that’s ok though, as it’s time to revisit the old so we can learn and the new can come in.” The unrest is also from everyone having to focus on themselves, so it’s not really a country problem. It’s a matter of trusting your own instinct and leading within, which is a benefit of this pandemic; everyone gets to figure out who they are.” Additionally, sometimes growth can come in the hard way.

“The next four years feels very similar to Lyndon Johnson’s presidency, with a smidgen of Abraham Lincoln’s presidency thrown into it. There is some more ground work to be finished, and Donald Trump will continue his work” says Sutliff.

For more details, visit https://psychicmediumkelle.com/

Share article on social media or email:

HumankindNOW offering testing and mental health services to health care workers fighting the COVID-19 pandemic


HumankindNOW brings critical COVID-19 testing and mental health services to health care workers in small businesses and underprivileged communities across the United States.

HumankindNOW today announced the availability of COVID-19 testing and mental health support services for front-line healthcare workers in small businesses and underprivileged communities.

These essential services, offered in partnership with Visit Healthcare, a provider of convenient and accurate medical testing, and Wellnesscoach.live, a wellness platform provider, along with donated personal protective equipment (PPE), help nurses, technicians and doctors combat the risks they face as they care for those afflicted with COVID-19.

“As our heroes on the front lines care for patients afflicted with COVID-19, many have told us that the stress of their work and fear for their own safety is taking an emotional toll. Through our partnerships with Visit Healthcare and Wellnesscoach.live, we can now do more to help those who are caring for our loved ones during this terrible pandemic,” said Chi-Chao Chang, Chairperson and CEO of HumankindNOW.

“We’re honored to partner with HumankindNOW to support health care workers battling COVID-19,” said Ben Fanger, CEO of Visit Healthcare. “Our community testing sites across California, Alaska, Illinois and Texas, as well as our mobile testing facilities, are at their service.”

“The stress of caring for people during a pandemic can be overwhelming, especially for health care workers,” said Julie Sharma, founder of Wellnesscoach.live. “We are pleased to make our coaching and support services for mental, physical and emotional well-being available to the heroes on the front lines.”

Health care workers, administrators and community officials can contact HumankindNOW at us@humankindnow.org for more information.

About HumankindNOW

HumankindNOW is a registered 501(c)(3) nonprofit in California dedicated to supporting front-line health care workers fighting the COVID-19 pandemic. Formed by leaders of Silicon Valley startups and fueled by $750,000 in donations, HumankindNOW has supplied 480,000 pieces of high-quality PPE to 11,000 health care workers in small businesses and underprivileged communities since its founding in March 2020. To learn more or to donate, go to humankindnow.org.

About Visit Healthcare

Our mission is to help slow the spread of COVID-19 by providing our clients and partners with convenient and accurate testing. With a united effort, we can help stem the tide of this virus and save many lives. To learn more, go to visit-healthcare.com.

About Wellnesscoach.live

Wellnesscoach.live is an all-encompassing digital wellness platform that provides real-time coaching and tools for mental, physical, social and financial well-being. Our platform helps teams all over the world weave wellness and overall well-being into their workplace. To learn more, go to wellnesscoach.live/about.

Share article on social media or email:

HomeoLux® Donates 100% Of Profits To Alzheimer’s Association In Support Of World Alzheimer’s Month


HomeoLux®, the health and technology company that designs wellness products based on cutting-edge scientific research, honors World Alzheimer’s Month by donating 100% of the proceeds from their premier product, BEACON40®, to the Alzheimer’s Association throughout September. With a singular focus on bringing hope and help to families battling cognitive decline, HomeoLux’s contribution aims to support Alzheimer’s care and research as well as help raise awareness of the devasting disease, its effects on so many lives, and lessen the stigma of dementia.

Every 66 seconds someone is diagnosed with Alzheimer’s disease and more than 50 million people worldwide are living with the disease. It is a cruel, progressive disease that impairs memory and other cognitive functions interfering with the daily life not just of the patient, but of everyone in the family. For the team at HomeoLux, Alzheimer’s disease is not only a global health crisis, but a personal mission as the company was established after CEO Terry Moore’s wife’s Alzheimer’s diagnosis in 2016. HomeoLux then developed the BEACON40® to improve brain health based off the cutting-edge science proving the positive impact of 40Hz gamma light rhythm on the brain. By donating the profits from the wellness device throughout World Alzheimer’s Month, it embodies the company’s mission and commitment to support all those affected by cognitive decline.

“Every month is World Alzheimer’s Month for families who are living with Alzheimer’s disease,” states Terry Moore, Co-Founder and CEO of HomeoLux. “We look forward to a day when this terrible disease has been defeated.” Moore added, “Until then, HomeoLux will continue to pool our resources to aid in the battle against Alzheimer’s disease as well as share our constructive and compassionate advice to help us through this battle, which we wage one day at a time.”

For World Alzheimer’s Month, HomeoLux also requests that people focus on raising awareness of the harm that stigmas surrounding Alzheimer’s disease cause, both to those who suffer from dementia and their caregivers. With raised awareness comes a greater commitment to find a cure for this shattering disease. Until that day, World Alzheimer’s Month is also a plea for the removal of the stigma of dementia, which is a further attack on the very humanity of those who suffer from it. Stigmas against Alzheimer’s discourage people who are living with the disease, or caring for someone who has it, from asking for the help and support they need. It also stops people from talking about their experiences, which means others lose the opportunity to benefit from their wisdom and leads to embarrassment that causes isolation as well as discomfort and fear. For families battling the devastation of Alzheimer’s and other dementia, that support cannot come soon enough.

Visit the HomeoLux website for additional details about BEACON40® and how to join the battle against Alzheimer’s disease and other dementias: https://hubs.li/H0wx1kM0.

ABOUT HOMEOLUX

HomeoLux® is a health and technology company that designs wellness products based on cutting-edge scientific research. Co-Founder and CEO Terry Moore, who is a respected management consultant a popular TED speaker, stepped out of retirement to launch the company when his wife was diagnosed with Alzheimer’s disease. HomeoLux delivers wellness technology that is safe and accessible, bringing hope and help to families battling cognitive decline. Visit the HomeoLux website for more details, https://HomeoLux.com

Share article on social media or email:

Smile Brands to provide free dental care for Healthcare Workers and First Responders with the OneSmile Dental Plan Membership


With a free year of the OneSmile Dental Plan Membership, we hope that we can deliver smiles to frontline workers at a time when they need it most.

Smile Brands Inc., one of the nation’s leading dental support organizations (DSO) providing business support services to approximately 450 affiliated offices across 18 states encourages patients at its Bright Now! Dental, Monarch Dental, Castle Dental, and other affiliated practices to enroll in the OneSmile Dental Plan in order to cost-effectively manage their dental health. As a way of showing its appreciation for healthcare workers and first responders during the COVID-19 pandemic, the company is offering the OneSmile Dental Plan membership free for 12 months. Group memberships will also be available at highly discounted rates, including $29 for the Couples Plan and $49 for the Family Plan. To take advantage of the OneSmile Dental Plan Healthcare Heroes offer ($79 savings), healthcare workers and first responders will need to show proof of employment when requesting the plan at any Smile Brands affiliated dental office.

“Since the start of the crisis, we’ve kept practices open so that patients with dental concerns could receive the care they need,” explains Smile Brands CEO, Steven C. Bilt. “We know it’s been tough on our teams to deal with the added safety measures and anxiety, and we want to show our support to fellow healthcare workers who continue to put patient needs first every day. With a free year of the OneSmile Dental Plan Membership, we hope that we can deliver smiles to frontline workers at a time when they need it most.”

The OneSmile Dental Plan helps patients access the dental care they need by offering plan members free preventive care and 20-40% off all dental services for a low annual fee. Over fifty thousand plan members enjoy savings on general dentistry, specialty, and orthodontic care, and individuals enrolling in the plan are much more likely to receive preventative care than the general population. The plan is available at all Smile Brands affiliated practices in Arizona, Arkansas, California, Colorado, Florida, Indiana, Maryland, Ohio, Oregon, Nevada, Pennsylvania, Tennessee, Texas, Utah, and Virginia.

The OneSmile Dental Plan Healthcare Heroes offer is valid on memberships initiated through December 31, 2020. Visit http://www.onesmiledentalplan.com/healthcare/ to learn more.

About Smile Brands Inc.

Based in Irvine California, Smile Brands Inc. is one of the largest providers of support services to dental groups in the United States. The organization’s award-winning culture has made it the only dental support organization on Glassdoor’s Best Places to Work for the past three years. Smile Brands’ affiliated dentists benefit from industry-leading business support services, so they can spend more time caring for patients and less time on the administrative, marketing, and financial aspects of operating a dental practice. The organization supports over 440 affiliated practices and 60 brands across 18 states. Smile Brands is a portfolio company of Gryphon Investors, a leading middle-market private equity firm based in San Francisco, CA. For more information, visit http://www.smilebrands.com.

Share article on social media or email:

Catalent Supports Rapid Development and Supply of Nocion Therapeutics’ Clinical Trial Materials for Acute and Chronic Cough Using Blow-Fill-Seal Technology


Blow-fill-seal technology offers many advantages for aseptic manufacturing. This proven platform has a low risk profile, and was ideal to accelerate development and production to meet the time frame of this project.

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today welcomed the news from Nocion Therapeutics, Inc., a biopharmaceutical company developing novel small molecule charged sodium channel blockers, that its first patient has been dosed with NOC-100, an inhaled formula of its NTX-1175 small molecule candidate.

NTX-1175 is being developed to treat cough and has received priority review through the U.K.’s Medicines and Healthcare products Regulatory Agency, as NOC-100 has the potential to treat both chronic and acute cough – the latter a common symptom in patients with COVID-19 and associated with transmission of the SARS-CoV-2 virus.

To support this program, Catalent rapidly developed and manufactured clinical-scale batches of blow-fill-seal (BFS) nebulizer ampules at its Woodstock, Illinois facility, a process it was able to accelerate from program inquiry to clinical supply in less than six months.

“Blow-fill-seal technology offers many advantages for aseptic manufacturing. This proven platform has a low risk profile, and was ideal to accelerate development and production to meet the time frame of this project,” commented Jonathan Arnold, President, Oral and Specialty Delivery at Catalent. He added, “Our deep expertise in complex BFS formulation and fully integrated services allowed us to respond very quickly to the needs of this new and important clinical trial that also has the potential to make a positive impact on COVID-19 patients.”

Catalent’s 430,000 square-foot facility in Woodstock is the company’s center of excellence for sterile liquid fill/finish, leveraging advanced aseptic BFS manufacturing technology. The site has over 35 years’ experience in providing BFS solutions for the most complex emulsions, suspensions and biologics, and houses over 30 BFS filling suites, as well as dedicated scale-up machinery, providing flexible capacity and services from early clinical stages through commercial production for ophthalmic, respiratory, topical, and biologic markets.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

About Nocion Therapeutics

Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers, “nocions”, that selectively affect actively firing nociceptors—to provide targeted, robust and sustained relief for the treatment of serious conditions involving cough, itch, and pain. The company’s mission is to safely alleviate suffering for millions of patients with conditions arising from activated sensory neurons. For more information, visit http://www.nociontx.com.

Share article on social media or email:

Reveleer Achieves HITRUST CSF ® Certification for Risk Management, Compliance, and Maximum Security


Reveleer, a SaaS software and services company that offers technology solutions for government-regulated healthcare plans, announced today that they gained the HITRUST CSF Certification for information security. The HITRUST certified status further demonstrates Reveleer’s commitment to their clients’ safety and meets the key requirements and industry regulations for properly managing risk and safeguarding confidential data. The attainment places Reveleer in an exclusive group of organizations that have achieved this coveted certification worldwide.

“Reveleer has always been at the forefront of technology, especially around data privacy and security.” said Jason Colbert, Senior Vice President of Technology. “More than HIPAA compliant, by achieving this HITRUST certification, our healthcare customers are assured the highest standards in the industry are in place to protect their sensitive data and information.”

The HITRUST CSF Certification is the benchmark for organizations to guard Protected Health Information (PHI) with regards to keeping secure any identifiable health, personal, and payment information held or transmitted electronically, on paper, or otherwise. The HITRUST Program includes federal and state regulations and frameworks and provides the standards of due care and due diligence for the protection of sensitive data. The program has become the framework for organizations in the healthcare industry to incorporate a comprehensive plan of security controls and risk-based methods for managing patient data.

“Reveleer and other healthcare organizations are under great pressure to meet complex regulations,” said Michael Loria CISO of Reveleer. “The HITRUST CSF is the gold-standard, and Reveleer is pleased to demonstrate our commitment to the highest levels of compliance and security by achieving HITRUST Certification.”

Reveleer completed a rigorous process to earn the HITRUST Certified status, including a validated assessment in which the CSF Assurance Program scores an organization’s adherence to HITRUST’s standard methodology, requirements, and controls. The HITRUST CSF Program provides the standardized methods to manage data, risk and compliance via information collection and reporting, and complies with national information security and privacy laws. The HITRUST CSF incorporates and synchronizes data protection requirements from many authoritative sources–such as HIPAA, ISO, NIST, PCI —and applies the appropriate security framework for an organization based on their regulatory risk factors. Reveleer obtained the HITRUST CSF Certification for the data protection standard in healthcare, known for its quality, thoroughness, and level of rigor in meeting industry requirements.

About Reveleer

Reveleer is a healthcare software and services company that uses Machine Learning and Intelligent Automation technology to empower payers in all lines of business to take control over their Quality Improvement and Risk Adjustment programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction, and reporting – all under one platform. Leveraging proprietary technology, robust data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.

Share article on social media or email:

Thermo Fisher Scientific Offers the Opportunity to “Ask” at the Applied Biosystems Genetic Analysis Virtual Conference, September 29 & 30, 2020


Thermo Fisher Scientific Offers the Opportunity to “Ask” at the Applied Biosystems Genetic Analysis Virtual Conference, September 29 & 30, 2020.

Serving as an opportunity to engage with fellow scientists in various genetic analysis fields, the Applied Biosystems Genetic Analysis virtual conference is being held virtually September 29–30, 2020, on the LabRoots platform, starting at 6am PDT, 9am EDT, 2pm BST, 3pm CEST, 4pm EEST.

Across the two days, a line-up of more than 30 leading researchers and scientists will share expertise on a wide variety of topics including, COVID-19 testing, infectious disease research as well as SARS-CoV-2, clinical oncology and cancer research, reproductive health and inherited disease research, polygenic risk scores and population health, pharmacogenomics, agrigenomics, and animal health.

Key education points for attendees (with credits awarded) will include:


  • Learn about TaqPath COVID-19 testing solutions, the impact flu season may have, and how Applied Biosystems are helping ‘back to life’ efforts.
  • Learn from clinical oncology and cancer research experts about the importance of chromosomal microarrays, MSI analysis, and immuno-oncology research.
  • Learn what it takes to achieve widespread adoption of polygenic risk scores in the clinic.

In addition to the talks and poster sessions, this event is an opportunity to ask questions surrounding genetic analysis research. There will be an Ask an Expert networking lounge, instrument demonstration hall, and exhibit hall showcasing Applied Biosystems research technologies such as real-time PCR, Sanger sequencing, microarray analysis, and others.

Geoffrey Cassell, PhD, Senior Market Development Manager at Thermo Fisher commented, “We are really excited to connect with other scientists during this time, and to offer this engaging opportunity to our customers.”

To view the full agenda and to register for the event, click here.

About Thermo Fisher Scientific

Thermo Fisher Scientific’s mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivalled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

About LabRoots

LabRoots is the leading scientific social networking website, as well as a primary source for scientific trending news, premier educational virtual events/webinars and more. Contributing to the advancement of science through content-sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining Continuing Education Credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email:

Ari’s Bears awards $30,000 grant for Ewing Sarcoma research, expanding legacy and vision of organization’s 10-year-old founder


News Image

Ari’s Bears, a not-for profit organization started by 10-year-old Ariella Stein, announced that it has selected Georgetown Lombardi Comprehensive Cancer as the recipient of a $30,000 grant, with the funds designated for Dr. Jeffrey Toretsky and the Pediatric Ewing Sarcoma Research Fund. Dr. Toretsky is conducting a clinical trial, currently in phase 2, on a targeted drug dubbed TK216.

This announcement, which was made during Childhood Cancer Awareness Month, marks the expansion of Ari’s Bears to include the provision of grants for pediatric cancer research. The foundation was initially created to provide comfort and bears to children in hospitals.

According to Erica Stein, Ariella’s mom and president of Ari’s Bears, the decision to expand the foundation’s reach while supporting Dr. Toretsky’s research is personal. “Ariella was diagnosed with Ewing Sarcoma, one of the rarer childhood cancers. The treatments she received throughout her initial diagnosis and then again during her relapse were developed decades ago. There is a severe shortage of federal research dollars for pediatric cancer research, which prevents scientists from developing innovative and effective treatments for children like Ariella. Dr. Toretsky’s research focuses on creating new and less toxic treatment options that we hope will benefit other families who have watched their children battle this insidious disease.”

On Tuesday, September 29, 2020 at 7:30PM EST, Ari’s Bears will host a virtual conference where Dr. Toretsky will present his work, discuss the clinical challenge of Ewing Sarcoma, and provide a synopsis of his research program that led to the TK216 drug in clinical trial. The event is free and open to the public, but registration is required: https://arisbears.org/events/dr-toretsky-zoom-conference/. A link will be provided to those who register.

About Ari’s Bears

Ari’s Bears, a 501(c)(3) nonprofit organization, funds pediatric cancer research, provides scholarships to pediatric cancer survivors, and delivers bears and other stuffed animals to sick children in hospitals. The brainchild of 10 year-old Ariella Stein, who at the time was undergoing grueling treatment for Ewing Sarcoma, the organization started with a simple idea: Ariella used her own money to purchase and make stuffed animals to deliver to other pediatric patients. When Ariella passed away at age 11 from complications from a bone marrow transplant, she had already delivered “Ari’s Bears” to seven local hospitals and respite houses. And her legacy is still being written. Since its inception in 2018, Ari’s Bears has gifted more than 2,000 bears and other stuffed animals to children in hospitals. To learn more, please visit https://arisbears.org.

Share article on social media or email:

Heilind Electronics Expands Sensor Offering with Sensata


Sensata - Cynergy3 sensors

Heilind is now offering an extensive range of Sensata – Cynergy3 pressure and depth sensors.

Heilind Electronics, a leading global distributor of electronic components and authorized distributor for Sensata – Cynergy3, recently added the manufacturer’s pressure sensors to its extensive sensor portfolio. A versatile solution for a variety of industries, these sensors use an electronic signal to measure pressure.

Sensata – Cynergy3 offers permanent and portable pressure sensors for the water industry, including custom solutions for water pressure monitoring. The company also manufactures industrial pressure sensors for use in paint spraying and injection molding, as well as sensors to monitor steam in medical sterilizers and subsea applications like submersibles.

Customers can choose from a variety of pressure and temperature ranges, as well as pressure types. Also available are a broad range of ceramic and silicon pressure sensors, fully customizable with options for pressure range, electrical output, pressure port, physical housing and seals — even at low volumes.

Visit Heilind’s website for more information about Sensata – Cynergy3’s Pressure Sensors.

About Heilind Electronics

Heilind Electronics, Inc. (http://www.heilind.com) is one of the world’s leading distributors of connectors, relays, sensors, switches, thermal management and circuit protection products, terminal blocks, wire and cable, wiring accessories and insulation and identification products. Founded in 1974, Heilind has locations throughout the U.S., Canada, Mexico, Brazil, Germany, Singapore, Hong Kong and China. Follow Heilind on Facebook at facebook.com/Heilind and on Twitter at twitter.com/Heilind.

About Cynergy3

Cynergy3, a brand of Sensata Technologies, is a leading manufacturer of liquid level and flow sensors, pressure and temperature sensors, control and instrumentation products, and high voltage and radio frequency reed relays. Cynergy3 has expanded its range of sensors over the past 40 years, while remaining at the forefront of high voltage and RF relay technology. The company is ISO 9001 certified, and most products are RoHS-compliant and conform to UL, CSA and CE standards.

Share article on social media or email: